Stay up to date with notifications from The Independent

Notifications can be managed in browser preferences.

New test detects cancer earlier

Jeremy Laurance
Tuesday 22 December 1998 00:02 GMT
Comments

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

A TEST for cervical cancer that can detect changes in the cells at an earlier stage than existing methods and could reduce misdiagnoses has been developed by scientists.

The system, which uses infra-red light to analyse the chemical composition of cells, can spot those in the earliest stage of becoming cancerous before the changes are visible under the microscope.

The discovery, by US researchers from Rockefeller University in New York, and the biotech company Digilab, in Cambridge, Massachusetts, is the third advance reported in the past 10 days which, it is claimed, could improve the accuracy of screening.

The others involve the use of antibodies to mark abnormal cells with a telltale dye to make them easier to recognise, and a technique of "liquid cytology" in which the cervical cells to be examined are first dispersed in liquid before being spread out on the slide to make them easier to see.

The latest development, reported in the US journal Proceedings of the Academy of Sciences, involved a study of cells taken from 10 healthy women, seven women with the pre-malignant stage of cervical cancer known as dysplasia and five with cervical cancer.

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in